Skip to content
The Nexus
DossierENTITY

cardiac remodelling

Coverage of cardiac remodelling in the Nexus archive.

Earliest in view: Apr 8 · 00:00 UTCMost recent: Apr 8 · 00:00 UTC
Co-mentioned in this coverage
Natureorganization1engineered immunosuppressive dendritic cellstopic1heart failuretopic1lesion-targeted immune modulationtopic1
Recent coverage
  • HEALTHApr 8 · 00:00 UTCNATURE NEWS
    Engineered immunosuppressive dendritic cells protect against cardiac remodelling

    A study published in Nature demonstrates that engineered immunosuppressive dendritic cells can protect against cardiac remodelling. Lesion-targeted immune modulation is identified as a feasible strategy to control cardiac fibrosis, with engineered dendritic cells emerging as a promising therapeutic platform for treating cardiac remodelling and heart failure.